Uploaded on Jan 17, 2023
The North American Betamethasone Price commenced the Q3 of 2022 on a positive note, with prices settled at USD 1095000 per MT in July. However, these prices eventually started plunging in August and falling even further to USD 1045000 per MT in September. The repeated lockdowns in China, from which most API are imported, forced manufacturers of Betamethasone to cut their prices. Consequently, demand from the downstream pharmaceutical sector in the United States reduced during the H2 of the quarter. Also, some manufacturing facilities in China were shut down for maintenance, significantly lessening imports into the US. All these factors had a prominent effect on the downward price trend of Betamethasone in the US domestic market.
Betamethasone Price Trend and Forecast
Betamethasone Price Trend and
Forecast
The final quarter of 2022 started positively for the North American
Betamethasone market, with prices settling at USD 1050000/MT in
October. Shortage of stock coupled with soaring demand from the
downstream pharmaceutical industry for the product were the main
causes at the back of the price increase. Many Chinese API production
facilities were shut down due to the Golden Week Holiday during the first
week of October, significantly reducing imports into the US. However,
these values eventually decreased from the start of the H2 of Q4 and
were assembled at USD 995000/MT in December. Demand from the
downstream sector declined during H2 as downstream entities were in a
solid wait-and-see attitude, forcing US suppliers to cut their prices to
increase orders.
https://www.chemanalyst.com/Pricing-data/betamethasone-1322
Betametha
sone Prices
in Asia
Market
Online
The Betamethasone Market
in The Asia Pacific Region
Showed Sluggish Market
The Betamethasone market in the Asia Pacific
region showed sluggish market sentiment
during the fourth quarter of 2022, with prices
falling from USD 920350/MT in October to
USD 896500/MT in December. A modest pace
of contraction in the manufacturing sector
this month was caused by the Golden week
closure of industrial facilities in China from
October 1 to October 7. After returning from
the Long Week Holiday, the market for
Betamethasone was underwhelming.
Following that, production, operations, and
logistics were uncertain as a result of the
continued lockdown measures in some
regions of China caused by an increase in
COVID-19 cases. Slow purchasing practices
were seen due to weak demand from
pharmaceutical sectors for Betamethasone as
buyers had a strong wait-and-see mentality,
which resulted in a declining price trend.
https://www.chemanalyst.com/Pricing-data/betameth
asone-1322
Betamethasone
Supply in Global
Market Online
Free Search Betamethasone
Pricing Online Market
•The market fundamentals for Betamethasone in Europe
were comparable to those in North America in the Q4 of
2022. However, CFR prices tended to rise to USD
999700/MT in the first half of the quarter. The reason
behind the surge was a persistent demand from end-user
sectors backed by a shortage of product inventories in the
German domestic market amid lesser imports from China.
Later in the second half, prices dropped and had reached
USD 961500/MT by the end of December. In this period,
players reported few inquiries from end-user
pharmaceutical industries due to the sluggish demand
and sufficient inventories of products in the German
market. The reason behind the accumulation was that
domestic merchants had excessive imports from Asia as
Chinese traders reduced price quotations, due to which
German buyers placed their orders in advance.
•https://www.chemanalyst.com/Pricing-data/betametha
sone-1322
Betamethas
one Price
Trend and
Forecast
Demand of Betamethasone North America Market
Find The Betamethasone Market Price Online
The final quarter of 2022 started positively for
the North American Betamethasone Market
The final quarter of 2022 started positively for the North American The market fundamentals for Betamethasone in Europe were
Betamethasone market, with prices settling at USD 1050000/MT in comparable to those in North America in the Q4 of 2022. However,
October. Shortage of stock coupled with soaring demand from the CFR prices tended to rise to USD 999700/MT in the first half of the
downstream pharmaceutical industry for the product were the main quarter. The reason behind the surge was a persistent demand from
causes at the back of the price increase. end-user sectors backed by a shortage of product
Contact Us:
ChemAnalyst
Contact No:- +1 3322586602
E-Mail:- [email protected]
websites:- www.chemanalyst.com
Comments